Illustration: Sarah Grillo/Axios

This month, Jaguar Health more than tripled the price of its lone FDA-approved drug, right after asking the federal government to expand the use of its drug to coronavirus patients.

Why it matters: Jaguar Health drastically raised the price of a drug during the height of the pandemic, but executives argued the move was needed to stave off the company's collapse.

By the numbers: Going into this year, the list price of a 60-pill bottle of Mytesi — an antidiarrheal medication specifically for people with HIV/AIDS who are on antiretroviral drugs — was $668.52.

  • On April 9, Jaguar Health raised the price to $2,206.52, according to pricing data from Elsevier's Gold Standard Drug Database.

Between the lines: The price hike coincides with the company's push to get its drug to more patients — specifically those diagnosed with COVID-19.

  • On March 21, Jaguar Health asked the FDA to authorize emergency use of Mytesi for COVID-19 patients who were experiencing any diarrhea or "diarrhea associated with certain antiviral treatments" including remdesivir, among others.
  • Jaguar Health argued Mytesi, which is made from the sap of trees in the Amazon rainforest, should be used more widely because researchers suggested diarrhea was a common symptom in coronavirus patients.
  • On April 7, the FDA denied that request. The agency declined to comment about why it denied the company's request.
  • Jaguar Health is still in discussions with the National Institute of Allergy and Infectious Diseases about evaluating Mytesi's effectiveness against this coronavirus.

The big picture: Jaguar Health disclosed earlier this month that "there is substantial doubt about our ability to continue as a going concern as we do not currently have sufficient cash resources to fund our operations" for another year.

  • Mytesi generated less than $6 million of revenue last year. Raising the drug's price threefold and shooting for a bigger patient population, especially coronavirus patients, would substantially increase revenue.

What they're saying: Jaguar Health CEO Lisa Conte told Axios the company decided in December to raise the price of Mytesi in April because it was losing too much money. She also blamed health insurers for making the drug difficult for people to get.

  • "The reimbursement barriers are so huge. It's impossible for us to make a business out of it," Conte said.
  • If the FDA granted emergency use for Mytesi during the coronavirus pandemic, the company would have held off on the price increase, Conte said. It delayed the price hike scheduled for April 1 until after it heard from the FDA.
  • When asked if the company would have increased Mytesi's price after any emergency use period lapsed, she replied: "Likely."
  • "[The price increase] is absolutely the right decision for everyone," Conte said.

Go deeper: Jaguar Health isn't the only drug company that has raised prices amid the outbreak. The U.S. drugmaker of chloroquine doubled the price of its product last month, the Financial Times reported.

Go deeper

CDC director says he was not involved in decision to change coronavirus data reporting

CDC director Robert Redfield testified Friday that he was not involved in the Trump administration's decision to bypass his agency and instead have hospitals send coronavirus data to the Health and Human Services Department.

Why it matters: According to the COVID Tracking Project, data on coronavirus hospitalizations has been "unstable since July 15" — five days after the change.

Updated 10 hours ago - Health

World coronavirus updates

Data: The Center for Systems Science and Engineering at Johns Hopkins; Map: Axios Visuals

The number of COVID-19 cases surpassed 20 million worldwide on Monday evening, Johns Hopkins data shows.

The big picture: World Health Organization chief Tedros Adhanom Ghebreyesus told a virtual press conference as the world approached the milestone that 750,000 deaths were set to be recorded this week. "Behind these statistics is a great deal of pain and suffering. Every life lost matters," he said. "But I want to be clear: there are green shoots of hope and... it's never too late to turn the outbreak around."

Updated 3 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Annelise Capossela/Axios

  1. Global: Total confirmed cases as of 3 a.m. ET: 20,092,855 — Total deaths: 736,254 Total recoveries — 12,350,879Map.
  2. U.S.: Total confirmed cases as of 3 a.m. ET: 5,094,565 — Total deaths: 163,465 — Total recoveries: 1,670,755 — Total tests: 62,513,174Map.
  3. Politics: Trump claims he would have not called for Obama to resign over 160,000 virus deathsHouse will not hold votes until Sept. 14 unless stimulus deal is reached.
  4. Business: Richer Americans are more comfortable eating out.
  5. Public health: 5 states set single-day coronavirus case records last week — A dual coronavirus and flu threat is set to deliver a winter from hell.
  6. Sports: The cost of kids losing gym class — College football is on the brink.
  7. World: Europe's CDC recommends new restrictions amid "true resurgence in cases."